Friday, September 17th 2021  
Plenary hall  Hall 2  Hall 3  Hall 4  
7:107:55  Breakfast Symposium 
7:107:55  Breakfast Symposium 

New challenges in distal RTA  Optimizing dialysis in children  
Chairs: Francesco Emma , Detlef Böckenhauer  Chairs: Rukshana Shroff, Günter Klaus  
dRTA and CKD, what do we really know?  Fernando Santos  Promoting life participation and an improved QoL in children on dialysis  Günter Klaus  
Bone disease in dRTA. Diagnosis and management  Carsten Wagner  
Growth and bone mineral density in dRTA patients. New results.  Aurelia BertholetThomas  More reasons to promote HDF in children  Rukshana Shroff  
8:00 8:45  Keynote  
Infection  the price of no rejection? Priya Verghese 

09:00  10:45  Session 1
Details

09:00  10:45  Session 2
Details

09:00  10:45  Pitch Session 1
Details

Pitch Session 2
Details


FSGS  CAKUT  Tubular Disorders  Transplantation 1  
Chairs: Marina Vivarelli , Jitske Jansen  Chairs: Elke Wühl , Rik Westland  Chairs: Detlef Böckenhauer, Marc Lilien  Chairs: Stephen Marks, Marlies Conelissen  
09:00  09:25  State of the Art  09:00  09:25  Controversy  09:00  09:09  PI1  PI12  
LDLapheresis in FSGS Ania Koziell 
Has the term CAKUT outlived its usefulness? Adrian Woolf vs. Nine Knoers 
09:09  09:18  PI2  PI13  
09:18  09:27  PI3  PI14  
09:25  09:38  OP1  09:25  09:38  OP5  09:27  09:36  PI4  PI15  
09:38  09:51  OP2  09:38  09:51  OP6  09:36  09:45  PI5  PI16  
09:51  10:04  OP3  09:51  10:04  OP7  09:45  09:54  PI6  PI17  
10:04  10:17  OP4  10:04  10:17  OP8  09:54  10:03  PI7  PI18  
10:20  10:45  State of the Art  10:20  10:45  State of the Art  10:03 10:12  PI8  PI19  
Basic science behind FSGS Moin Saleem 
Prenatal programming of the kidney Michiel Schreuder 
10:12  10:21  PI9  PI20  
10:21  10:30  PI10  PI21  
10:30  10:39  PI11  PI22  
10:4511:15  BREAK + Live stream from the studio: "Patients meet researchers"  
11:15  13:00  Session 3
Details

11:15  13:00  Session 4
Details

11:15  13:00  Pitch Session 3
Details

Pitch Session 4
Details


Complementmediated kidney disease  CalciumPhosphate axis  Diagnostic Procedures & Basic Science  AKI  
Chairs: Gema Ariceta, Nicole van de Kar  Chairs: Justine Baccetta, Rukshana Shroff  Chairs: Moin Saleem, Martine Besouw  Chairs: Martin Christian, Francesco Emma  
11:15  11:40  State of the Art  11:15  11:40  Controversy  11:15  11:24  PI23  PI34  
How to treat C3G in the light of its pathophysiology? Matthew Pickering 
Vitamin D vs. calcimetics to optimize bone health in CKD Claus Schmit vs. Justine Bacchetta 
11:24  11:33  PI24  PI35  
11:33  11:42  PI25  PI36  
11:40  11:53  OP9  This abstract has been withdrawn  11:40  12:05  State of the Art  11:42  11:51  PI26  PI37  
11:53  12:06  OP10  Interplay between bone and vessels in children with CKD  Alexander Lalayiannis  11:51  12:00  PI27  PI38  
12:06  12:19  OP11  12:05  12:18  OP13  12:00  12:09  PI28  PI39  
12:19  12:32  OP12  12:18  12:31  OP14  12:09  12:18  PI29  PI40  
12:35 13:00  State of the Art  12:35  13:00  Practical approach  12:18  12:27  PI30  PI41  
Complement inhibition in STECHUS Sally Johnson 
Dietetic management in children with CKD Rukshanna Shroff with dietician 
12:27  12:36  PI31  PI42  
12:36  12:45  PI32  PI43  
12:45  12:54  PI33  PI44  
13:1514:15  Lunch Symposium 
13:1514:15  Lunch Symposium 
13:1514:15  LUNCH  
Cystine depletion therapy in patients with cystinosis: from clinical studies to routine practice  Illuminating the patient journey for children with PH1. Challenges, outcomes, and unmet needs in the management of PH1  
Welcome & Introduction  Jun Oh  Welcome & introduction  Justine Bacchetta  
Optimizing Cystine Depletion Therapy: longterm efficacy and safety data from clinical studies  Elena Levtchenko  Identifying and managing PH1 in children  Rezan Topaloğlu  
Adherence to cysteamine in nephropathic cystinosis patients: a unique electronic monitoring experience for a better understanding  Aurelia BertholetThomas  Clinical trial updates in PH1  Sander Garrelfs  
Cystine Depletion Therapy in patients with Cystinosis: the optimal monitoring in routine clinical practice  Gema Ariceta  Questions & Answers  All  
Closing & Remarks  Jun Oh  
14:30  16:15  Session 5  14:30  16:15  Session 6
Details

14:30 16:15  Pitch Session 5
Details

Pitch Session 6
Details


Ethical Dilemmas  Hypertension  CKD 1  AKI & CRRT/CKD  
Chairs: Eduard Verhagen, Justina Bacchetta  Chairs: George Reusz, Marc Lilien  Chairs: Evgenia Preka, Jun Oh  Chairs: Jaap Mulder, Marina Vivarelli  
14:30 15:05  State of the Art  14:30  14:55  State of the Art  14:30  14:39  PI45  PI56  
What a paediatric nephrologist should know about paediatric palliative care Eduard Verhagen 
Renovascular hypertension Jelena Stojanovic 
14:39  14:48  PI46  PI57  
14:48  14:57  PI47  PI58  
14:55  15:08  OP15  14:57  15:06  PI48  PI59  
15:05  15:40  State of the art  15:08  15:21  OP16  15:06  15:15  PI49  PI60  
New therapies: Facing societal costs and ethical concerns  Michel Clanet  15:21  15:34  OP17  15:15  15:24  PI50  PI61  
15:34  15:54  Hot topics in pediatric hypertension  15:24  15:33  PI51  PI62  
15:40  16:15  State of the art  Latest in BP Assessment and HTN Management in Pediatrics  Joseph Flynn  15:33  15:42  PI52  PI63  
Cultural issues: What Western pediatric nephrologists should know about treating nonwestern patients Christina Taylan 
15:42  15:51  PI53  PI64  
15:54  16:14  Hot topics in pediatric hypertension  15:51  16:00  PI54  PI65  
Cardiovascular Risk in Pediatric CKD, ESRD and Transplant  Priya Verghese  16:00  16:09  PI55  PI66  
16:1516:45  BREAK + Live stream from the studio: "Ethics meets reality"  
16:45  18:00  Session 7
Details

16:45 18:00  Session 8
Details

16:30  18:15  Pitch Session 7
Details

Pitch Session 8
Details


Glomerulonephritis  Challenges in adolescence and at transition  CKD 2  COVID  
Chairs: Augustina Jankauskiene, Tomas Seeman  Chairs: Michiel Oosterveld, Max Liebau  
Chairs: Aleksandra Zurowska, Stephen Marks, Olivia Boyer  Chairs: Joanna van Wijk , Markus Josef Kemper  16:30  16:39  PI67  PI78  
16:39  16:48  PI68  PI79  
16:45  17:10  State of the Art  16:45  17:10  State of the Art  16:48  16:57  PI69  PI80  
Serum and podocyte markers of membranous nephropathy Pierre Ronco 
Transition: the journey from paediatric patient to adulthood Paul Harden 
16:57  17:06  PI70  PI81  
17:06  17:15  PI71  PI82  
17:15  17:24  PI72  PI83  
17:10  17:23  OP18  17:10  17:23  OP20  17:24  17:33  PI73  PI84  
17:23  17:36  OP19  17:23  17:36  OP21  17:33  17:42  PI74  PI85  
17:36  18:00  State of the Art  17:36  18:00  State of the Art  17:42 – 17:51  PI75  PI86  
New treatments for lupus nephritis Stephen Marks 
Puber brain Lydia Krabbendam 
17:51  18:00  PI76  PI87  
18:00  18:09  PI77  PI88  
18:0019:30  GENERAL ASSEMBLY  